FDA inspection

Pharmaplast S.A.E.: FDA inspection ending Nov 10, 2022

FDA inspection 1190349 · Official Action Indicated (OAI) · Alexandria

Key facts

Inspection ID 1190349
Firm Pharmaplast S.A.E.
FEI number 3003767891
Address Amria Free Zone, 30 Beside Lord International Factory Building
City Alexandria
Country Egypt
Fiscal year 2023
Inspection end date Nov 10, 2022
Classification Official Action Indicated (OAI)
Project area Drug Quality Assurance
Product type Drugs
Warning letter 648883

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • Yes Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections